Calcified Lesions: CTO Strategies for Plaque Preparation

Vascular calcification is a predictor of difficult stent positioning and expansion, which increases the chance of device failure (even with last generation stents). Calcium modifying strategies are being developed to reduce these difficulties. 

Lesiones calcificadas: OCT de estrategias para la preparación de placa

Two recent randomized studies compare different calcium preparation devices. The PREPARE-CALC compares rotational atherectomy (RA) against plaque modifying balloons (PMB = cutting / scoring balloons) and the ISAR-CALC compares super high-pressure balloons (SHPB) against PMB. In both studies, stent expansion was assessed by optical coherence tomography.

Patient-level data from both randomized trials were pooled to look at the efficacy of the different strategies to prepare severely calcified lesions. 

Between September 2014 and October 2017 data from 200 patients were obtained. The strategies involved rotational atherectomy with Rotablator, scoring balloons (AngioSculpt, Angioscore or ScoreFlex), cutting balloons (Flextome) and super high-pressure balloons (OPN).

Read also: TCT 2022 | RADIANCE II Pivotal Trial.

Primary end point was stent expansion assessed by CTO.  Secondary end points were stent eccentricity, stent asymmetry, acute lumen gain, strategy success and in-hospital adverse cardiovascular events.

Rotational atherectomy was used in 63 patients, plaque modifying balloons in 103 and super high-pressure balloons in 34. They were mostly men, with multivessel disease, and target lesions mostly in the anterior descending. 

RA vs. PMB or SHPB preparation rendered comparable stent expansion (73.2%±11.6 vs 70.8%±13.6%vs 71.8%±12%, P=0.49), and protocol analysis showed the same results. Patients treated with SHPB saw less stent eccentricity compared to RA (0.74±0.09 vs 0.70±0.06 vs 0.70±0.08, P=0.03), with similar results at protocol analysis. Acute lumen gain was numerically hihger when lesions were prepared with SHPB vs. RA and PMB (1.88±0.43 vs 1.69±0.38 vs 1.79±0.41, P=0.08). 

Read also: TCT 2022 | BYPASS CTCA.

Strategy success was higher with RA compared against PMB and SHPB (100% vs 86.4% vs 91.2%, P ¼ 0.002); crossover requiring RA as complementary strategy occurred in 5.8% of the PMB and 8.8% of the SHPB patients. Target vessel MI during procedure happened in 3.2% of RA and 2.9% of SHPB patients, with no differences. 

Conclusions

Looking at these CTO data pooled from randomized studies, we’ve found that RA, PMB and SHPB presented comparable stent expansion, while SHPB showed the best eccentricity. Strategy success was higher with RA.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board SOLACI.org.

Original Title: Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions.

Font: Rheude T, Fitzgerald S, Allali A, et al. Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions. JACC Cardiovasc Interv. 2022;15(18):1864-1874. doi:10.1016/j.jcin.2022.07.034.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....